Esprinet S.p.A. (BIT:PRT)
| Market Cap | 285.53M +18.0% |
| Revenue (ttm) | 4.29B +3.6% |
| Net Income | 20.17M -6.3% |
| EPS | 0.41 -5.1% |
| Shares Out | 49.44M |
| PE Ratio | 14.15 |
| Forward PE | 10.22 |
| Dividend | 0.35 (6.15%) |
| Ex-Dividend Date | May 4, 2026 |
| Volume | n/a |
| Average Volume | 232,408 |
| Open | 5.69 |
| Previous Close | 5.78 |
| Day's Range | 5.69 - 5.92 |
| 52-Week Range | 3.53 - 6.69 |
| Beta | 1.20 |
| RSI | 58.50 |
| Earnings Date | May 13, 2026 |
About Esprinet
Esprinet S.p.A., together with its subsidiaries, engages in the wholesale distribution of information technology (IT) products and consumer electronics in Italy, Spain, Portugal, and rest of Europe. The company distributes air conditioning, audio, DIY and gardening, electricity and lighting, gaming, mobility, navigation, networking, printing, sports and leisure, TV and home cinema, and video surveillance and access control products; bags, backpacks, and suitcases; drones; home appliances; mobile phones and landline phones; monitors; musical ins... [Read more]
Financial Performance
In 2025, Esprinet's revenue was 4.29 billion, an increase of 3.63% compared to the previous year's 4.14 billion. Earnings were 20.17 million, a decrease of -6.26%.
Financial StatementsNews
Esprinet SpA (STU:EP4A) Q4 2025 Earnings Call Highlights: Strong Iberian Growth Amid Strategic ...
Esprinet SpA (STU:EP4A) Q4 2025 Earnings Call Highlights: Strong Iberian Growth Amid Strategic Shifts
Q4 2025 Esprinet SpA Earnings Call Transcript
Q4 2025 Esprinet SpA Earnings Call Transcript
Esprinet Earnings Call Transcript: Q4 2025
FY25 delivered 5% sales growth, strong Iberian performance, and stable EBITDA, with a strategic focus on value-added segments and sustainability. Leadership transitions smoothly to Giovanni Testa, and 2026 guidance will be provided in May.
Esprinet Names Roberto Sasso Chief Financial Officer
(RTTNews) - Esprinet S.p.A. (PRT.MI), a B2B distributor of Information Technology, on Monday said it has appointed Roberto Sasso as Chief Financial Officer.
Esprinet SpA (FRA:EP4A) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ...
Esprinet SpA (FRA:EP4A) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
Q3 2025 Esprinet SpA Earnings Call Transcript
Q3 2025 Esprinet SpA Earnings Call Transcript
Esprinet Earnings Call Transcript: Q3 2025
Q3 2025 saw solid growth in revenue, gross profit, and EBITDA, with strong performance in Spain and Portugal offsetting a flat Italian market. Working capital and net debt improved significantly, and the Vammat acquisition is set to boost green tech growth. Guidance for full-year EBITDA adjusted remains at the upper end of EUR 63–71 million.
Esprinet SpA (FRA:EP4A) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ...
Esprinet SpA (FRA:EP4A) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges
Q2 2025 Esprinet SpA Earnings Call Transcript
Q2 2025 Esprinet SpA Earnings Call Transcript
Esprinet Earnings Call Transcript: Q2 2025
Q2 2025 saw strong 5% revenue growth and a 38% EBITDA increase, offsetting a weak Q1 and driving H1 profitability. Focus remains on high-margin segments, with guidance maintained at EUR 63-71 million EBITDA adjusted, targeting the upper end amid ongoing offering rationalization and macro uncertainties.
Esprinet Earnings Call Transcript: Q1 2025
Q1 2025 delivered strong sales and gross profit growth, led by V-Valley and Zeliatech, but margins were pressured by inflation and higher costs. Guidance for 2025 is cautious, focusing on cost and working capital optimization amid ongoing market unpredictability.
Esprinet Earnings Call Transcript: Q4 2024
Strong FY2024 results with 8% EBITDA growth and 6% sales increase, driven by digital, infrastructure, and green tech segments. Outlook for 2025 is positive, with focus on PC refresh, AI, and working capital optimization. Dividend reinstated at €0.40 per share.
Esprinet Earnings Call Transcript: Q3 2024
Q3 2024 delivered strong sales growth and market outperformance, especially in Solutions and Services, despite margin pressure in Devices. Guidance for full-year adjusted EBITDA is EUR 66–71 million, with robust Q4 momentum and positive long-term outlook.
Esprinet Earnings Call Transcript: H1 2024
Q2 2024 saw a return to growth with 9% higher adjusted EBITDA, improved cash cycle, and market share gains, especially in solutions and services. Outlook remains positive, with guidance maintained and long-term growth expected from digital transformation and AI trends.